Epigral Ltd
NSE:EPIGRAL

Watchlist Manager
Epigral Ltd Logo
Epigral Ltd
NSE:EPIGRAL
Watchlist
Price: 2 121.1 INR 0.16% Market Closed
Market Cap: 88.1B INR
Have any thoughts about
Epigral Ltd?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

EPIGRAL Price Targets Summary
Epigral Ltd

Wall Street analysts forecast EPIGRAL stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPIGRAL is 2 040 INR with a low forecast of 2 020 INR and a high forecast of 2 100 INR.

EPIGRAL Lowest Forecast
Wall Street Target
2 020 INR
5% Downside
EPIGRAL Average Forecast
Wall Street Target
2 040 INR
4% Downside
EPIGRAL Highest Forecast
Wall Street Target
2 100 INR
1% Downside
Lowest
Price Target
2 020 INR
5% Downside
Average
Price Target
2 040 INR
4% Downside
Highest
Price Target
2 100 INR
1% Downside
Epigral Ltd Competitors:
Price Targets
300041
Hubei Huitian New Materials Co Ltd
27% Upside
603977
Jiangxi Guotai Group Co Ltd
33% Upside
ARPL
Arla Plast AB
6% Downside
603217
Yuanli Chemical Group Co Ltd
13% Upside
300041
Hubei Huitian New Materials Co Ltd
27% Upside
603977
Jiangxi Guotai Group Co Ltd
33% Upside
ARPL
Arla Plast AB
6% Downside
603217
Yuanli Chemical Group Co Ltd
13% Upside
KANSAINER
Kansai Nerolac Paints Ltd
16% Upside
P
PCHEM
Petronas Chemicals Group Bhd
11% Upside
UNIP6
Unipar Carbocloro SA
118% Upside

Revenue
Forecast

Revenue Estimate
Epigral Ltd

For the last 2 years the compound annual growth rate for Epigral Ltd's revenue is 12%. The projected CAGR for the next 3 years is 22%.

12%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Epigral Ltd

For the last 2 years the compound annual growth rate for Epigral Ltd's operating income is -8%. The projected CAGR for the next 3 years is 27%.

-8%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Epigral Ltd

For the last 2 years the compound annual growth rate for Epigral Ltd's net income is -12%. The projected CAGR for the next 3 years is 33%.

-12%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
EPIGRAL intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIGRAL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIGRAL stock valuation using valuation multiples.
Wall Street Estimates
EPIGRAL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIGRAL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPIGRAL's stock price target?
Price Target
2 040 INR

According to Wall Street analysts, the average 1-year price target for EPIGRAL is 2 040 INR with a low forecast of 2 020 INR and a high forecast of 2 100 INR.

What is Epigral Ltd's Revenue forecast?
Projected CAGR
22%

For the last 2 years the compound annual growth rate for Epigral Ltd's revenue is 12%. The projected CAGR for the next 3 years is 22%.

What is Epigral Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 2 years the compound annual growth rate for Epigral Ltd's operating income is -8%. The projected CAGR for the next 3 years is 27%.

What is Epigral Ltd's Net Income forecast?
Projected CAGR
33%

For the last 2 years the compound annual growth rate for Epigral Ltd's net income is -12%. The projected CAGR for the next 3 years is 33%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 193,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.